These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 30955239)
21. Genetic polymorphisms of pharmacogenomic VIP variants in the Lisu population of southwestern China: A cohort study. Li B; Wang L; Lei L; Zhang M; Niu F; Chen P; Jin T Medicine (Baltimore); 2018 Sep; 97(38):e12231. PubMed ID: 30235667 [TBL] [Abstract][Full Text] [Related]
22. Genetic Analysis of Pharmacogenomic VIP Variants of ABCB1, VDR and TPMT Genes in an Ethnically Isolated Population from the North Caucasus Living in Jordan. Al-Eitan LN; Al-Maqableh HW; Mohammad NN; Hakooz NM; Dajani RB Curr Drug Metab; 2020; 21(4):307-317. PubMed ID: 32368972 [TBL] [Abstract][Full Text] [Related]
23. Genetic polymorphisms of pharmacogenomic VIP variants in the Hui population from Ningxia Province of China. Zhou W; Guo J; Li Y; Ma X; Yang S; Wei J; Zhang H; Zhang S; Jin T Funct Integr Genomics; 2023 Mar; 23(2):85. PubMed ID: 36930384 [TBL] [Abstract][Full Text] [Related]
24. Genetic Polymorphisms of Pharmacogenomic VIP Variants in the Circassian Subpopulation from Jordan. Al-Eitan LN; Mohammad NN; Al-Maqableh HW; Hakooz NM; Dajani RB Curr Drug Metab; 2019; 20(8):674-681. PubMed ID: 31362667 [TBL] [Abstract][Full Text] [Related]
25. Population genetic difference of pharmacogenomic VIP gene variants in the Lisu population from Yunnan Province. Zhang C; Jiang X; Chen W; Li Q; Yun F; Yang X; Dai R; Cheng Y Medicine (Baltimore); 2018 Dec; 97(52):e13674. PubMed ID: 30593137 [TBL] [Abstract][Full Text] [Related]
26. Deciphering DMET genetic data: comprehensive assessment of Northwestern Han, Tibetan, Uyghur populations and their comparison to eleven 1000 genome populations. Zhang J; Wang H; Niu G; Liu Y; Wang Y; Zhang L; Pei Y; Zhu H; Dai P; Chen C Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S1176-S1185. PubMed ID: 30688101 [TBL] [Abstract][Full Text] [Related]
27. Analysis of pharmacogenomic very important pharmacogenomic variants: Meng W; Zhang W; Yang S; Dou X; Liu Y; Li H; Liu J; Jin T; Li B Per Med; 2022 Sep; 19(5):403-410. PubMed ID: 35801384 [No Abstract] [Full Text] [Related]
28. The population genetics of pharmacogenomics VIP variants in the Sherpa population. Wang L; Ren Y; Shi X; Yuan D; Liu K; Geng T; Li G; Kang L; Jin TB Drug Metab Pharmacokinet; 2016 Feb; 31(1):82-89. PubMed ID: 26825850 [TBL] [Abstract][Full Text] [Related]
29. The landscape of very important pharmacogenes variants and potential clinical relevance in the Chinese Jingpo population: a comparative study with worldwide populations. Ma X; Li Y; Zang X; Guo J; Zhou W; Han J; Liang J; Wan P; Yang H; Jin T Cancer Chemother Pharmacol; 2024 May; 93(5):481-496. PubMed ID: 38300251 [TBL] [Abstract][Full Text] [Related]
30. Very important pharmacogenetic variants landscape and potential clinical relevance in the Zhuang population from Yunnan province. Li Y; Chang Y; Yan Y; Ma X; Zhou W; Zhang H; Guo J; Wei J; Jin T Sci Rep; 2024 Mar; 14(1):7495. PubMed ID: 38553524 [TBL] [Abstract][Full Text] [Related]
31. Analysis of Very Important Pharmacogenomics Variants in the Chinese Lahu Population. Cheng Y; Li Q; Yang X; Ding H; Chen W; Dai R; Zhang C Pharmgenomics Pers Med; 2021; 14():1275-1289. PubMed ID: 34629888 [TBL] [Abstract][Full Text] [Related]
32. HLA-DPB1 polymorphism in Blang and Puyi ethnic groups of southwest China inferred from sequence-based typing. Wang B; Hu W; Wang J; Li S; Yu H; Tang W; Tan S; Shou W; Zhang J; Xiao C Tissue Antigens; 2008 Jan; 71(1):81-4. PubMed ID: 17971047 [TBL] [Abstract][Full Text] [Related]
33. Genetic variation of pharmacogenomic VIP variants in Zhuang nationality of southern China. Liu Y; Li H; Cao K; Liu J; Sun Y; Wu J; Xiong Z; Niu F; Li J; Jin T Pharmacogenomics J; 2021 Feb; 21(1):60-68. PubMed ID: 32699276 [TBL] [Abstract][Full Text] [Related]
34. Pharmacogenetic landscape of Metabolic Syndrome components drug response in Tunisia and comparison with worldwide populations. Jmel H; Romdhane L; Ben Halima Y; Hechmi M; Naouali C; Dallali H; Hamdi Y; Shan J; Abid A; Jamoussi H; Trabelsi S; Chouchane L; Luiselli D; Abdelhak S; Kefi R PLoS One; 2018; 13(4):e0194842. PubMed ID: 29652911 [TBL] [Abstract][Full Text] [Related]
35. Genomic Scans of Zygotic Disequilibrium and Epistatic SNPs in HapMap Phase III Populations. Hu XS; Hu Y PLoS One; 2015; 10(6):e0131039. PubMed ID: 26126177 [TBL] [Abstract][Full Text] [Related]
36. Ethnic variability in the allelic distribution of pharmacogenes between Korean and other populations. Kim IW; Kim KI; Chang HJ; Yeon B; Bang SJ; Park T; Kwon JS; Kim S; Oh JM Pharmacogenet Genomics; 2012 Dec; 22(12):829-36. PubMed ID: 22955668 [TBL] [Abstract][Full Text] [Related]
37. Population Genetic Difference of Pharmacogenomic VIP Variants in the Tibetan Population. He C; Peng L; Xing S; Li D; Wang L; Jin T Pharmgenomics Pers Med; 2021; 14():1027-1040. PubMed ID: 34429635 [TBL] [Abstract][Full Text] [Related]
38. Genetic polymorphism of pharmacogenomic VIP variants in the Deng people from the Himalayas in Southeast Tibet. Shi X; Wang L; Du S; Wang H; Feng T; Jin T; Kang L Biomarkers; 2015 Jul; ():1-12. PubMed ID: 26227544 [TBL] [Abstract][Full Text] [Related]
39. Genetic polymorphism of pharmacogenomic VIP variants in the Deng people from the Himalayas in Southeast Tibet. Shi X; Wang L; Du S; Wang H; Feng T; Jin T; Kang L Biomarkers; 2015; 20(5):275-86. PubMed ID: 26329523 [TBL] [Abstract][Full Text] [Related]
40. Genetic polymorphisms of very important pharmacogene variants in the Chinese Lisu population. Lu H; Zhang Z; Wang Y; Wang L; Yuan D; He Y; Jin T Per Med; 2023 May; 20(3):239-249. PubMed ID: 37427690 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]